A detailed history of Foster Dykema Cabot & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 9,395 shares of PFE stock, worth $243,236. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,395
Previous 6,995 34.31%
Holding current value
$243,236
Previous $257,000 21.4%
% of portfolio
0.04%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $77,016 - $90,024
2,400 Added 34.31%
9,395 $312,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $62,523 - $72,338
1,731 Added 32.88%
6,995 $257,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $15,519 - $20,204
394 Added 8.09%
5,264 $215,000
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $313,292 - $408,968
-7,504 Reduced 60.64%
4,870 $250,000
Q3 2022

Feb 03, 2023

BUY
$43.76 - $53.42 $328,375 - $400,863
7,504 Added 154.09%
12,374 $541,000
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $8,576 - $10,470
-196 Reduced 1.56%
12,374 $541,000
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $304,923 - $377,838
-6,665 Reduced 34.65%
12,570 $651,000
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $2,024 - $3,001
-49 Reduced 0.25%
19,235 $1.14 Million
Q3 2021

Oct 25, 2021

SELL
$39.25 - $50.42 $4,867 - $6,252
-124 Reduced 0.64%
19,284 $829,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1,759 - $1,993
49 Added 0.25%
19,408 $760,000
Q1 2021

May 03, 2021

SELL
$33.49 - $37.77 $224,918 - $253,663
-6,716 Reduced 25.76%
19,359 $701,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $224,784 - $285,832
6,716 Added 34.69%
26,075 $960,000
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $12,890 - $15,123
-406 Reduced 2.05%
19,359 $710,000
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $8,102 - $9,829
-269 Reduced 1.34%
19,765 $646,000
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $14,062 - $15,450
375 Added 1.91%
20,034 $851,000
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $5,231 - $5,964
-136 Reduced 0.69%
19,659 $858,000
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $827 - $1,003
-24 Reduced 0.12%
19,795 $872,000
Q2 2018

Aug 06, 2018

SELL
$32.98 - $35.16 $8,277 - $8,825
-251 Reduced 1.25%
19,819 $765,000
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $9,892 - $11,476
-310 Reduced 1.52%
20,070 $712,000
Q4 2017

Jan 31, 2018

SELL
$33.26 - $35.29 $4,656 - $4,940
-140 Reduced 0.68%
20,380 $738,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $636,120 - $700,758
20,520
20,520 $733,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Foster Dykema Cabot & CO Inc Portfolio

Follow Foster Dykema Cabot & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & CO Inc with notifications on news.